The outcomes of 429 patients from 153 sites in the Platelet glycoprotein IIb/IIIa in unstable angina : Receptor Suppression Using Integrilin Therapy ( PURSUIT ) trial , who were transferred during study drug infusion ( `` transfer patients '' ) , were compared with those of 1,987 patients who either remained in the hospital at those sites or were transferred after study drug termination ( `` nontransfer patients '' ) .
